Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-28

Clinical Trial Update: Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN) [Phase 2]

View source ↗

Summary

Phase 2 study assessing the bioavailability of a melatonin-rich food supplement administered sublingually and orally.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin-rich food supplement (melatonin)

Snippet

Sponsor: Technological Centre of Nutrition and Health, Spain | Conditions: Biological Availability | Phase 2 | Status: COMPLETED